Investor News

August 6, 2008 - Additional Listing

Cyprotex PLC 

(“Cyprotex“ or “the Company“)

Cyprotex PLC (AIM: CRX), the drug discovery, technology and information company, today announces that it has issued 50,000 new ordinary shares of 0.1p each (“new Ordinary Shares“) pursuant to the exercise options.

The issue of these new Ordinary shares is subject to the new Ordinary Shares being admitted to trading on AIM, application for which has been made. Trading in the new Ordinary Shares, which will rank pari passu in all respects with the existing ordinary shares, is expected to commence on 8 August 2008.

For further information:

Cyprotex PLC
Dr Anthony Baxter, CEO
Tel: +44 (0)1625 505 100
ir@cyprotex.com
www.cyprotex.com

Russell Gibbs, CFO
Tel: +44 (0)1625 505 100
ir@cyprotex.com
www.cyprotex.com

Nomura Code Securities Limited
Charles Walker
Tel: +44 (0)20 7776 1200
cew@nomuracode.com
Giles Balleny
ghb@nomuracode.com